Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial
Titel:
Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial
Auteur:
Konstantinopoulos, Panagiotis A Barry, William T Birrer, Michael Westin, Shannon N Cadoo, Karen A Shapiro, Geoffrey I Mayer, Erica L O'Cearbhaill, Roisin E Coleman, Robert L Kochupurakkal, Bose Whalen, Christin Curtis, Jennifer Farooq, Sarah Luo, Weixiu Eismann, Julia Buss, Mary K Aghajanian, Carol Mills, Gordon B Palakurthi, Sangeetha Kirschmeier, Paul Liu, Joyce Cantley, Lewis C Kaufmann, Scott H Swisher, Elizabeth M D'Andrea, Alan D Winer, Eric Wulf, Gerburg M Matulonis, Ursula A